The Newcastle Molecular Pathology Node recently hosted the event ‘Molecular Diagnostics at Newcastle University’ as part of NAHP Industry Month.
The one-day event, which took place on 2nd March 2017, was designed to showcase work undertaken as part of the Pathology Node. The event also brought industry partners to Newcastle University, to allow potential collaborations with industry and Node research community, around molecular diagnostics and image analysis.
The Newcastle Molecular Pathology Node is funded by the Medical Research Council and is a valued partner in the development of stratified medicine within the NIHR Newcastle Biomedical Research Centre. Within the Node’s Biomedical research theme, the Node links with some key areas of translational research already underway at Newcastle University – two areas of which are also supported by the NIHR Newcastle Biomedical Research Centre; liver disease research and mitochondrial disease research.
Work undertaken by the Node, facilitates the links with industry by providing techniques and tools that enable the adoption of new technologies into the NHS; a key objective for the NIHR Biomedical Research Centres.
The event held on 2nd March was opened by Pro Vice Chancellor and lead for the NIHR Newcastle BRC dementia theme, Professor David Burn.
Presentations on current biomedical research in mitochondria, paediatric cancer, adult cancer, fibrosis and circulating tumour cell research was delivered throughout the morning, to an audience made up of researchers, industry colleagues and business development managers from the Trust and University.
The afternoon included sessions on digital and molecular imaging at Newcastle and a slot on tissue access and the new CePa biobank.
The event welcomed attendees from an array of industry companies such as High Force Research, Selex, Nanostring and Leica, and led to several potential collaborations.
Find out more about the Newcastle Molecular Pathology Node